Cargando…
Giant cell arteritis: is the clinical spectrum of the disease changing?
BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and trea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664782/ https://www.ncbi.nlm.nih.gov/pubmed/31357946 http://dx.doi.org/10.1186/s12877-019-1225-9 |
_version_ | 1783439957639036928 |
---|---|
author | González-Gay, Miguel Á. Ortego-Jurado, Miguel Ercole, Liliana Ortego-Centeno, Norberto |
author_facet | González-Gay, Miguel Á. Ortego-Jurado, Miguel Ercole, Liliana Ortego-Centeno, Norberto |
author_sort | González-Gay, Miguel Á. |
collection | PubMed |
description | BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. DISCUSSION: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. CONCLUSIONS: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications. |
format | Online Article Text |
id | pubmed-6664782 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-66647822019-08-05 Giant cell arteritis: is the clinical spectrum of the disease changing? González-Gay, Miguel Á. Ortego-Jurado, Miguel Ercole, Liliana Ortego-Centeno, Norberto BMC Geriatr Debate BACKGROUND: Giant cell arteritis is a vasculitis of large and middle-sized arteries that affects patients aged over 50 years. It can show a typical clinical picture consisting of cranial manifestations but sometimes nonspecific symptoms and large-vessel involvement prevail. Prompt diagnosis and treatment is essential to avoid irreversible damage. DISCUSSION: There has been an increasing knowledge on the occurrence of the disease without the typical cranial symptoms and its close relationship and overlap with polymyalgia rheumatica, and this may contribute to reduce the number of underdiagnosed patients. Although temporal artery biopsy is still the gold-standard and temporal artery ultrasonography is being widely used, newer imaging techniques (FDG-PET/TAC, MRI, CT) can be of valuable help to identify giant cell arteritis, in particular in those cases with a predominance of extracranial large-vessel manifestations. CONCLUSIONS: Giant cell arteritis is a more heterogeneous condition than previously thought. Awareness of all the potential clinical manifestations and judicious use of diagnostic tests may be an aid to avoid delayed detection and consequently ominous complications. BioMed Central 2019-07-29 /pmc/articles/PMC6664782/ /pubmed/31357946 http://dx.doi.org/10.1186/s12877-019-1225-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Debate González-Gay, Miguel Á. Ortego-Jurado, Miguel Ercole, Liliana Ortego-Centeno, Norberto Giant cell arteritis: is the clinical spectrum of the disease changing? |
title | Giant cell arteritis: is the clinical spectrum of the disease changing? |
title_full | Giant cell arteritis: is the clinical spectrum of the disease changing? |
title_fullStr | Giant cell arteritis: is the clinical spectrum of the disease changing? |
title_full_unstemmed | Giant cell arteritis: is the clinical spectrum of the disease changing? |
title_short | Giant cell arteritis: is the clinical spectrum of the disease changing? |
title_sort | giant cell arteritis: is the clinical spectrum of the disease changing? |
topic | Debate |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664782/ https://www.ncbi.nlm.nih.gov/pubmed/31357946 http://dx.doi.org/10.1186/s12877-019-1225-9 |
work_keys_str_mv | AT gonzalezgaymiguela giantcellarteritisistheclinicalspectrumofthediseasechanging AT ortegojuradomiguel giantcellarteritisistheclinicalspectrumofthediseasechanging AT ercoleliliana giantcellarteritisistheclinicalspectrumofthediseasechanging AT ortegocentenonorberto giantcellarteritisistheclinicalspectrumofthediseasechanging |